IP Library Granted Patent US 11,737,899
Granted Patent B2
US 11,737,899 · App. 16/792,094 · Granted Aug 29, 2023

Intragastric device

Inventors: Mark C. Brister (Encinitas, CA); Paul D. Faucher (Escondido, CA); Neil R. Drake (San Diego, CA); Andrew P. Rasdal (San Diego, CA); Matthew S. Lake (Carlsabd, CA); Dubravka Markovic (San Diego, CA); Amy D. L. VandenBerg (San Diego, CA); Antonio C. Llevares (Chula Vista, CA); Josefina Nider (San Diego, CA)
Assignee: RESHAPE LIFESCIENCES INC.
A61F5/003A61F5/0036A61F5/0089A61M25/10181A61M29/02A61M25/10185
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,737,899
App. No.
16/792,094
Granted
Aug 29, 2023
Kind
B2
Abstract

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Claims (29)

1. An intragastric balloon system comprising:

an intragastric balloon comprising:

a polymeric wall with an inner surface defining a balloon lumen;

a self-sealing valve system attached to the polymeric wall's inner surface,

an erodible seam directly or indirectly coupled to the polymeric wall that is configured to degrade based on an internal environment of the intragastric balloon inside the balloon lumen instead of an external environment outside the intragastric balloon;

an outer container releasably containing the intragastric balloon in a folded and compacted state, the outer container comprising:

an outer container wall formed of a material that is erodible in an in vivo gastric environment;

an outer container interior; and

an opening in the outer container wall, the opening in the outer container wall providing fluid communication between the outer container interior and the in vivo gastric environment; wherein

the outer container is sized and shaped so as to be swallowable by normal peristaltic motion;

a swallowable inflation catheter comprising:

catheter tubing with an open proximal end and open distal end joined by a catheter lumen;

a needle assembly attached to the catheter tubing distal end

a catheter connector attached to the catheter tubing proximal end; and

a tensile cord extending through the catheter lumen and attached to each of the needle assembly and the catheter connector.

2. The system of claim 1 , further comprising:

an inflation source container comprising:

a volume of an inflation fluid, wherein the inflation fluid comprises at least water;

an inflation valve in fluid communication with the volume of the inflation fluid; wherein

the inflation valve is sized and shaped to reversibly connect to the catheter connector; and wherein

the inflation valve includes opened and closed configurations and an actuation handle.

3. The system of claim 1 , wherein the polymeric wall comprises one or more layers.

4. The system of claim 3 , wherein the polymeric wall comprises a barrier material comprising nylon and polyethylene.

5. The system of claim 3 , wherein the polymeric wall comprises a barrier material comprising nylon, polyvinylidene chloride and polyethylene.

6. The system of claim 1 , wherein the inflation catheter is of a variable stiffness.

7. The system of claim 1 , wherein the inflation catheter tubing is from 1 French to 6 French in diameter.

8. The system of claim 1 , wherein the erodible seam is configured to degrade based on a pH or a humidity condition in the internal environment of the intragastric balloon inside the balloon lumen.

9. The system of claim 1 , wherein the balloon lumen is configured to be filled with water.

10. The system of claim 9 , wherein the erodible seam is configured to degrade based on the water in the internal environment of the intragastric balloon inside the balloon lumen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2025
From: RESHAPE LIFESCIENCES INC.
To: MEDTIMO INC.
Reel/Frame 072955/0766 →
SECURITY INTEREST Recorded Oct 24, 2024
From: RESHAPE LIFESCIENCES INC.
To: ASCENT PARTNERS FUND LLC
Reel/Frame 070166/0882 →
CHANGE OF NAME Recorded Oct 6, 2021
From: OBALON THERAPEUTICS, INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 057726/0716 →